Personalization Improved Survivorship Care Plan Adherence in Breast Cancer Patients

Article

A randomized trial showed that personalized care plans and one-on-one counseling can improve adherence to survivorship plans among low-income breast cancer survivors.

A randomized trial showed that personalized care plans and one-on-one counseling can improve adherence to survivorship plans among low-income breast cancer survivors. The results will be presented at the upcoming American Society of Clinical Oncology (ASCO) Cancer Survivorship Symposium in San Francisco.

Rose C. Maly, MD, of the David Geffen School of Medicine at UCLA, presented the study, and said during a press call that there is little data on the actual implementation of survivorship care plans. Low-income survivors in particular often face challenges with regard to accessing care.

The new study randomized 212 low-income women with stage 0–III breast cancer to either usual care or a survivorship intervention. The intervention involved a questionnaire to highlight specific needs-such as hot flashes, sexual dysfunction, weight gain, and other issues-with personalized recommendations based on that questionnaire. The women in the intervention group also received an hour-long counseling session with a survivorship care nurse, in which the women were coached to ask their physicians to help implement a survivorship plan.

There were 105 women in the control group and 107 in the intervention group. Adherence to care plans was measured with quarterly adherence surveys and a follow-up interview at 12 months after the intervention.

The control group had a 51.1% adherence rate, compared with 60.6% in the intervention group (P = .045). Also, the women reported better physician implementation of their plans, at 52.6% in the control group and 64.6% in the intervention group (P = .015). Maly said the improvement in adherence remained significant even after controlling for a number of potentially confounding factors.

Merry-Jennifer Markham, MD, of the University of Florida College of Medicine and an ASCO expert who was not involved with the study, noted that there are over 14.5 million cancer survivors in the United States today, and that number is expected to increase beyond 19 million within a decade.

“There is no standard best way to implement these [survivorship] plans in order to improve patient outcomes,” Markham said. “I think it’s the combination-the survivorship care plan and the one-on-one counseling … that may be the key to improved survivorship outcomes.”

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.